Criteria for the Development and Validation of Radiomic Tests in Diagnosis and Treatment of Prostate Cancer
Erich Huang, PhD, examines the rapid growth and evolving role of radiomics in oncology, particularly in prostate cancer.
Read More
Video
Novel and Emerging Pathological Factors in Localized and Recurrent Prostate Cancer
Gladell P. Paner, MD, discusses novel and emerging pathological factors in localized prostate cancer, highlighting recurrent cases.
Read More
Optilume for BPH
Sunchin Kim, MD, offers an in-depth exploration of OptilumeⓇ, a novel therapy for benign prostatic hyperplasia (BPH).
Read More
SUI – AUA/SUFU Guidelines 2017 — Amendment 2023
Suzette E. Sutherland, MD, MS, URPS, discusses the AUA and SUFU guidelines for evaluating and treating stress urinary incontinence (SUI). In this five-minute talk, Dr. Sutherland reviews the five key components for evaluating a patient with SUI and discusses indications for advanced diagnostic tools such as cystoscopy and urodynamics.
Dr. Sutherland’s discussion continues with the Guideline’s treatment options, both non-surgical (pessaries, vaginal inserts, and pelvic floor muscle exercises), and surgical (bulking agents, midurethral slings). The recent amendment to the guidelines now allows clinicians to offer single-incision slings alongside retropubic and transobturator slings for patients, reflecting their comparable safety and effectiveness.
AUA Guidelines on Neurogenic Lower Urinary Tract Dysfunction
Stephen R. Kraus, MD, MBA, FACS, reviews the updated neurogenic lower urinary tract dysfunction (N-LUTD) guidelines, previously known as neurogenic bladder guidelines. In this 10-minute talk, he notes that the redefined terminology reflects a more comprehensive approach, addressing both bladder and outlet dysfunction.
Kraus explains patients are classified into low, moderate, or high-risk categories based on factors like neurological disease and bladder function. The guidelines use these categories when recommending treatment. Dr. Kraus gives examples, illustrating how the guidelines provide individualized patient treatment. Further, he emphasizes that the guidelines highlight the importance of ongoing monitoring to ensure treatment efficacy and prevent complications in high-risk patients.
Read More